Skip to main content
Home
language-selector-globe Portugal | pt
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe Portugal
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • Sobre nós 
      • Novartis em Portugal 
      • A nossa História 
      • A nossa Missão e Visão 
      • Os nossos Valores 
      • Direção do Grupo Novartis 
      • Pessoas e Cultura 
      • Estratégia 
      • Contactos 
      sobre-nos Sobre nós
    • Doentes e Cuidadores 
      • Doenças 
      • Produtos 
      • Reportar Eventos Adversos 
      • O Compromisso da Novartis para com Doentes e Cuidadores 
      A couple holding hands Doentes e Cuidadores
    • Profissionais de saúde 
      • Recursos para Profissionais de Saúde 
      • Áreas de Investigação 
      • Produtos 
      • MedHub 
      • Novartis Pipeline 
      • Apoios Novartis a organizações externas 
      • Reportar Eventos Adversos 
      • Terapias Celulares e Genéticas 
      • Ensaios Clínicos 
      Profissionais de Saúde - Retrato de uma médica a olhar para a câmara Profissionais de saúde
    • Investigação e Desenvolvimento 
      • Projetos Novartis 
      • Scicare - Novartis Health Science Accelerator 
      • Tech Care 
      Investigação e desenvolvimento - Cientistas homens a trabalhar no laboratório Investigação e Desenvolvimento
    • ESG 
      • Ética, Risco e Compliance 
        • Comportamento Ético 
      • Acesso 
      • Sustentabilidade Ambiental 
      • Saúde Global 
      • Iniciativas locais 
      • Relatórios 
        • Materiality Assessment 
        • Transferências de valor a Profissionais e Organizações de Saúde 
      Young patients waiting outside hospital in Rwanda ESG
    • Notícias 
      • Arquivo de notícias 
      • Histórias 
      • Publicações 
      • Comunicados de Imprensa 
      • Contactos de Imprensa 
      Notícias - Reunião informal no átrio Notícias
    • Carreiras 
      • Como trabalhamos 
      • Bem-estar 
      • Crescimento Pessoal 
      • Diversidade e Inclusão 
      • Prémios e Reconhecimento 
      • Expedition Novartis 
      • Procurar vagas 
      Sede da Novartis em Portugal Carreiras
    • Coronavirus 
      Coronavirus under microscope Coronavirus
    Cientistas a trabalhar no laboratório Página Inicial
  1. Home
  2. Carreiras
  3. Procurar vagas
  • Sort by Sort ascending
  • Cargo
  • Site
  • Localização
  • Divisão
  • Negócio
  • Functional Area Sort descending
  • Data de publicação
Cargo Site Localização Divisão Negócio Functional Area Sort descending Data de publicação
Public Affairs Manager (m/f/d) Berlin West (Non-Sales Force) (Novartis Pharma GmbH) Germany International Innovative Medicines Communications & Public Affairs Julho 09, 2024
Patient Engagement Lead İstanbul Kavacık Turkey Corporate Affairs CTS Communications & Public Affairs Set 03, 2024
Public Affairs Manager Ankara Gimat Turkey International Innovative Medicines Communications & Public Affairs Set 13, 2024
Manager, Post Production & Video Services Hyderabad (Office) India Corporate Affairs CTS Communications & Public Affairs Out 04, 2024
Associate Director, R&D Portfolio and Engagement - Communications Cambridge (Massachusetts) USA Corporate Affairs CTS Communications & Public Affairs Out 08, 2024
Associate Director, Finance and Strategy & Growth Activation Communications East Hanover USA Corporate Affairs CTS Communications & Public Affairs Out 08, 2024
Lead - Government Affairs Delhi (Office) India International Innovative Medicines Communications & Public Affairs Out 15, 2024
Comms & Engagement Manager Amsterdam Netherlands Corporate Affairs CTS Communications & Public Affairs Out 16, 2024
Executive Director, Therapy Area Communications and Patient Advocacy Basel (City) Switzerland Corporate Affairs CTS Communications & Public Affairs Out 16, 2024
Communication & Patient Advocacy Manager (f/m/d) Vienna Austria International CTS Communications & Public Affairs Set 24, 2024
Associate Director, Corporate Event Marketing East Hanover (New Jersey) USA Corporate Affairs CTS Communications & Public Affairs Out 22, 2024
Director of Global & Swiss Media & Editorial Basel (City) Switzerland Corporate CTS Communications & Public Affairs Out 18, 2024
Manager, Corporate Communications Montreal Canada Corporate Affairs CTS Communications & Public Affairs Out 21, 2024
Associate Director, Business Transformation & Engagement Barcelona Gran Vía Spain Development Innovative Medicines Communications & Public Affairs Out 23, 2024
Director of Commercial Policy Communications and Media Relations, Europe Basel (City) Switzerland Corporate Affairs CTS Communications & Public Affairs Out 24, 2024
Associate Director, Political Affairs & Insights Washington, DC USA Corporate Affairs Corporate Communications & Public Affairs Out 22, 2024
EA & Program Coordinator Beijing (Beijing) China Corporate Affairs Innovative Medicines Communications & Public Affairs Out 22, 2024
Government Affairs Manager Moscow (City) Russian Fed. Corporate Affairs Innovative Medicines Communications & Public Affairs Out 22, 2024
Chef, Communications corporatives Montreal Canada Corporate Affairs CTS Communications & Public Affairs Out 21, 2024
(Sr.) Public Affairs Manager Taipei Taiwan International Innovative Medicines Communications & Public Affairs Out 20, 2024
Sr. Spec. IT Solution Delivery INSURGENTES Mexico Operations CTS Information Technology Julho 15, 2024
Senior Specialist DDIT OPS Mfg Site IT Sasayama Japan Operations CTS Information Technology Julho 22, 2024
Sr. Spec. DDIT IES Supplier Management Hyderabad (Office) India Operations CTS Information Technology Out 18, 2024
Specialist - Product Complaints - QOP Hyderabad (Office) India Operations Innovative Medicines Quality Set 03, 2024
Specialist - Quality Operations Hyderabad (Office) India Operations Innovative Medicines Quality Set 03, 2024
Specialist - Quality Operations Hyderabad (Office) India Operations Innovative Medicines Quality Set 03, 2024
QC Specialist I - Analytical Tuas South Avenue Singapore Operations Innovative Medicines Quality Set 03, 2024
QC Specialist II - Analytical Tuas South Avenue Singapore Operations Innovative Medicines Quality Set 03, 2024
QualityTeamLeader,QA Ops-Mfg Mgt(QA USP) Tuas South Avenue Singapore Operations Innovative Medicines Quality Set 03, 2024
Associate Manager - Quality Operations Hyderabad (Office) India Operations Innovative Medicines Quality Set 03, 2024
QC Analyst/ Specialist Tuas South Avenue Singapore Operations Innovative Medicines Quality Set 13, 2024
Quality Assurance Manager - QP/RP Amsterdam Netherlands Operations Innovative Medicines Quality Set 17, 2024
QC Specialist II (m/f/d), Schaftenau, Tirol Schaftenau Austria Operations Innovative Medicines Quality Out 03, 2024
QA Compliance Expert – Reg CMC Facilitator Schaftenau Austria Operations Innovative Medicines Quality Out 03, 2024
Specialist upravljanja kakovosti dobaviteljev II (m/ž/d)/ QA supplier management specialist II (m/f/d) Ljubljana Slovenia Operations Innovative Medicines Quality Out 03, 2024
Senior Quality Manager (m/f/d) Schaftenau Austria Development Innovative Medicines Quality Out 03, 2024
QC Analyst IV Tuas South Avenue Singapore Operations Innovative Medicines Quality Out 03, 2024
QC Analyst III Tuas South Avenue Singapore Operations Innovative Medicines Quality Out 03, 2024
AD, Patient Support Center - Program Monitoring Arizona USA US Innovative Medicines Quality Out 04, 2024
Global GMP Expert Quality Auditor Mumbai (Head Office) India Operations Innovative Medicines Quality Out 07, 2024
QC Site Manager / Responsable CQ - pharmacien adjoint SCL - H/F Saint-Cloud France Operations Innovative Medicines Quality Set 03, 2024
Associate Director Data Ops & Analytics, RDQ Hyderabad (Office) India Development Innovative Medicines Quality Set 03, 2024
Specialist - QA Ops - Manufacturing Mgmt Tuas South Avenue Singapore Operations Innovative Medicines Quality Set 03, 2024
AS&T Hub Team Coordinator İstanbul Kurtköy Turkey Operations Innovative Medicines Quality Set 03, 2024
Labortechniker / QC Analyst II (m/w/d), Kundl, Tirol Kundl Austria Operations Innovative Medicines Quality Set 26, 2024
QC Specialist II (m/w/d) Kundl, Tirol Kundl Austria Operations Innovative Medicines Quality Set 26, 2024
Vodja skupine kontrole kakovosti v QLS Velike Molekule / Vodja laboratorija Bioanalitika (m/f/d), Mengeš Mengeš Slovenia Operations Innovative Medicines Quality Set 27, 2024
Innovation Manager Hyderabad (Office) India Operations Innovative Medicines Quality Set 30, 2024
Specialist - Quality Operations Hyderabad (Office) India Operations Innovative Medicines Quality Set 03, 2024
Specialist – Quality Operations Hyderabad (Office) India Operations Innovative Medicines Quality Set 03, 2024

Pagination

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 42
  • › Next page

Novartis Portugal

Navegar na Novartis
  • Doentes e Cuidadores
  • Profissionais de Saúde
  • ESG
  • Notícias
  • Carreiras
Notícias
  • Arquivo de Notícias
  • Histórias
O nosso Portefólio
  • Novartis Pipeline
  • Portefólio de Produtos Novartis
Outros websites Novartis
  • MedHub PT
  • Website Global
Footer Bottom
© 2024 Novartis Portugal
  • Política de Privacidade
  • Termos de Utilização
  • Acessibilidade
  • Configurações de cookies
  • Mapa do site
Diretório dos sites da Novartis
Este site destina-se ao público em Portugal